40 results on '"Fejzo, Marlena S."'
Search Results
2. Contributors
3. Author’s reply
4. Inaccuracies in “Long-term health outcomes of children born to mothers with hyperemesis gravidarum: a systematic review and meta-analysis”
5. Patterns of Use and Self-reported Effectiveness of Cannabis for Hyperemesis Gravidarum
6. Whole‐exome sequencing uncovers new variants inGDF15associated with hyperemesis gravidarum
7. Analysis in epithelial ovarian cancer identifies KANSL1 as a biomarker and target gene for immune response and HDAC inhibition
8. HyperEmesis Level Prediction (HELP Score) Identifies Patients with Indicators of Severe Disease: a Validation Study
9. Nausea and Vomiting of Pregnancy and HG Risk Genes Associated With Blood Levels, Sleep, Stomach Pain, and Other Traits [23N]
10. Nausea and vomiting of pregnancy and hyperemesis gravidarum
11. Critique of inaccurate reporting in Edlavitch article on “Publishing negative findings and the challenge of avoiding type II errors in studies of suspect teratogens: Example of a recent ondansetron publication”
12. Proteasome ubiquitin receptor PSMD4 is an amplification target in breast cancer and may predict sensitivity to PARPi
13. Genetic Approaches Reveal a Non-Hormonal Etiology for Hyperemesis Gravidarum [7L]
14. Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States
15. Why are Women Still Dying from Nausea and Vomiting of Pregnancy?
16. Intestinal obstruction is a rare complication of ondansetron exposure in hyperemesis gravidarum
17. ADRM1‐amplified metastasis gene in gastric cancer
18. Neurodevelopmental delay in children exposed in utero to hyperemesis gravidarum
19. Psychiatric factors do not affect recurrence risk of hyperemesis gravidarum
20. Antihistamines and other prognostic factors for adverse outcome in hyperemesis gravidarum
21. Dacomitinib, an Irreversible Pan-ErbB Inhibitor Significantly Abrogates Growth in Head and Neck Cancer Models That Exhibit Low Response to Cetuximab
22. Hyperemesis gravidarum: it is time to put an end to the misguided theory of a psychiatric etiology
23. Change in paternity and recurrence of hyperemesis gravidarum
24. Risk factors, treatments, and outcomes associated with prolonged hyperemesis gravidarum
25. Posttraumatic stress symptoms following pregnancy complicated by hyperemesis gravidarum
26. Knockdown of ovarian cancer amplification target ADRM1 leads to downregulation of GIPC1 and upregulation of RECK
27. Familial aggregation of hyperemesis gravidarum
28. Recurrence Risk of Hyperemesis Gravidarum
29. Periostin promotes ovarian cancer angiogenesis and metastasis
30. Lapatinib, a Dual EGFR and HER2 Kinase Inhibitor, Selectively Inhibits HER2-Amplified Human Gastric Cancer Cells and is Synergistic with Trastuzumab In vitro and In vivo
31. Patients with a history of hyperemesis gravidarum have similar symptoms during egg stimulation and develop ovarian hyperstimulation syndrome: case series
32. Symptoms and Pregnancy Outcomes Associated with Extreme Weight Loss among Women with Hyperemesis Gravidarum
33. High Prevalence of Severe Nausea and Vomiting of Pregnancy and Hyperemesis Gravidarum Among Relatives of Affected Individuals
34. High prevalence of severe nausea and vomiting of pregnancy and hyperemesis gravidarum among relatives of affected individuals
35. Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target
36. Elective pregnancy termination in a large cohort of women with hyperemesis gravidarum
37. Symptomatology and outcomes of women with hyperemesis gravidarum as reported in a large registry
38. Familial aggregation of hyperemesis gravidarum
39. Psychosocial burden of hyperemesis gravidarum
40. Characterization of Genes Encoding Known and Novel Human Mast Cell Tryptases on Chromosome 16p13.3
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.